Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Prevention of Postoperative Delirium in Elderly Patients Undergoing Craniotomy
NCT05168280Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2022
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postoperative delirium (POD) comparing DEX group with Placebo group (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05168280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168280.